Notably, this CD137 upregulation with anti-PD1 therapy fits with our previous findings,13 while expression of KLRB1 is associated with reactivated cytotoxic CD8+ T cells38 within the TME and correlates with better outcomes in several different cancers.39 This evidence concerns the gene CD8A and cancer.